The urinary excretion of tritiated folic acid after a single intravenous injection in man has been measured by Johns, Sperti, and Burgen (1). Plasma concentrations of the labeled compound fell sharply initially, and then more slowly. Urinary clearance in terms of the later, slowly declining plasma levels was shown, at plasma concentrations above 10 jug per L, to be independent of plasma level and to average 51 ml per minute. The finding of an upper fixed limit lower than the glomerular filtration rate (130 to 140 ml per minute) was correlated with binding of folic acid to plasma proteins. Ultrafiltration and equilibrium dialysis demonstrated a practically uniform binding over the concentration range of 5 to 3,000 ug per L, with an average of 64%o. The renal excretion of folic acid at these high plasma levels could be accounted for simply by glomerular filtration and urinary excretion of unbound folic acid. At plasma levels lower than 10 ug per L, the urinary clearance appeared to decline, suggesting some renal tubular reabsorption of folic acid, but no threshold plasma concentration was defined, suggesting a relatively ineffective renal mechanism for the conservation of folic acid. At these lower plasma concentrations, the accuracy of the data was not great because of the low levels of radioactivity involved.
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Tritium-labeled folic acid of much higher specific activity has now become available. This material has been used in the present study to investigate more completely the renal excretion of folic acid by the single renal intra-arterial injection technique (2) . 
METHODS
(General cxpcrincntal procednrc. In each experiment a mixture of folic acid and inulin was placed in a single syringe and rapidly injected into the left renal artery of a dog anesthetized with pentobarbital. Twenty-five or more samples of urine were collected in the ensuing 10 minutes, and the recoveries of test substances in each sample were determined. Within each experiment, collection periods of constant duration were used; this duration varied from one experiment to another, however, depending on the rate of urine flow, and ranged from 20 to 38 seconds per sample.
Materials and injection solution. The following special materials were used: tritiated folic acid,1 mixed with carrier folic acid for some experiments, purified before each experiment by chromatography on DEAE cellulose (1), the SA after purification ranging from 13 Muc per mg to 637 Mkc per mg; carrier folic acid; 2 inulin, recrystallized from ethanol; 3 inulin -COOH C14, 2.09 mc per g; 4 and methotrexate (4-amino-N'-methylpteroylglutamic acid).5
The materials to be inj ected were mixed together in solution, and a sample was removed for the preparation of standard solutions. The mixture was then diluted with saline or plasma to yield 0.5 to 1.0 ml injection solution. When tritium and C'4 were both present, the carbon activity utilized was adjusted so that it was approximately 3 to 5% of the tritium activity.
Operative procedure and collection of samples. Mongrel dogs, anesthetized with pentobarbital, weighing 13 to 26 kg were experimental subjects. The renal artery was exposed through a left flank incision, and Teflon catheters were placed in the ureters either through a split bladder or in an extravesicular position. To facilitate collection and analysis of specimens, urine flow was increased by using a 15% urea infusion 6 to levels of from 0.5 to 9.8 ml per minute. The injection mixture was introduced into the left renal artery with a bent needle, and subsequent urine samples were collected in vials placed in a timed urine-collection rack.7 The volume of each sample was determined by weighing. At the end of each experiment, the left kidney was excised and weighed. Analysis of samples. Standard solutions were prepared from the injection mixture by addition, in serial dilution, of blank urine obtained just before the experiment. Inulin was determined chemically by the method of Higashi and Peters (3) . Radioactivity was determined in a Packard Tri-Carb liquid scintillation counter at 5°C. In each experiment uniform portions of each sample and of the diluted standard solutions were added to 10 ml scintillator made up as follows: 77 ml dioxane, 23 ml ethanol, 13.3 g naphthalene, 25 mg 1,4-bis-2-(5-phenyloxazolyl)benzene (POPOP), and 1 g 2,5-diphenyloxazole (PPO). Where the samples contained both tritium and C14 activity, double-channel counting was utilized. Two calibration samples of blank urine, one containing only tritium and the other containing only C'4 activity, were used to adjust the two channels so that less than 5% of the first channel tritium counts appeared in the second channel and the carbon counts appearing in the first channel did not greatly exceed those appearing in the second channel. With this setting of the channels, counts of the calibration samples led to a pair of simultaneous equations that could be solved for the tritium and C14 activity present in each sample counted. Addition of tritiated toluene of known activity demonstrated that the quenching properties for tritium activity of the uniform portions of urine were the same throughout a given experiment.
In an attempt to identify the nature of the radioactive compounds present in the urine after a displacing dose of unlabeled folic acid, a 5-ml sample of urine was chromatographed by the procedure previously described (1) .
RESULTS
Urinary excretion after a single intra-arterial injection. The results for a given experiment were calculated as follows (2) . The amount of material excreted in each sample was expressed as a fraction of the amount injected. The material excreted in a given sample by the control right kidney was assumed to result from the recirculation of injected material, and was subtracted from the corresponding experimental left sample to yield the net first passage urinary excretion from the experimental side. The net urinary excretion of inulin and of folic acid was then plotted as a function of time.
The inulin curve rose to a peak and then decayed to zero, whereas the folic acid curve rose to a peak and then died away to some continued very low level of urinary excretion of activity, most evident when high doses were used. This was regarded as a steady state leak of urinary radioactivity independent of the first passage phenomenon, and the first passage excretion was Figure 1A ). At low-dose levels, where the urinary recovery was very small, the symmetry was less marked: the folic acid curve was flattened so that the peak was much lower, and the downstroke tended to approach the downstroke of the inulin curve ( Figure 1B ). At high-dose levels, where the inulin and folic acid excretion curves were symmetrical on a semilogarithmic plot, the mean transit times (cor- rected for catheter lag) of inulin and folic acid were virtually identical ( Table I ). The curves of Figure 1 , A and B, were plotted on rectangular coordinates in the lower panel of Figure 1 . The time relationship of the curves is no longer evident from inspection.
To compare experiments in different animals, the dosage was expressed in terms of micrograms of folic acid injected per 10 g of experimental kidney. This will not allow for variations in blood flow or filtration fraction, but is a provisional way of obtaining a basis for comparison. Cumulative first passage urinary excretion of folic acid was calculated from the curves for each experiment and expressed as the ratio of the coincident urinary excretion of inulin. The data are illustrated in Figure 2 , and it is evident that at small doses there was relatively complete reabsorption of the injected folic acid. As the dose was increased the proportion reabsorbed diminished, until at very large doses the amount appearing in the urine reached an asymptotic value of 71% of the cumulative inulin recovery.
The protein-binding of folic acid was examined by ultrafiltration of dog plasma containing folic acid at 370 C with CO2 at a partial pressure of 40 mm Hg (Figure 3 ) by use of Toribara tubes (4). The proportion ultrafiltered was practically uniform over the concentration range explored and average(I 67 ± 8 SDo. The coincidence of this value with the asymptotic ratio of urinary fractional recoveries of folic acid to inulin indicated that at high values the folic acid appearing in the' urine corresponded to that passing into the glomerular fluid. The line shown in Figure 2 was constructed on the premise that 71%o of the folic acid is filtrable at the glomerulus, that all the folic acid filtered is reabsorbed up to a dose level of 0.32 /g per 10 g kidney, and that all the filtered folic acid above this dose level appears in the urine. It is evident that to a first approximation this fits the data.
The amount reabsorbed in each experiment may be calculated from the data. If the proportion ultrafiltered is assumed to be 0.71, then under these experimental conditions, the amount reabsorbed is essentially equivalent to the amount filtered up to a maximum of 0.04 ug per 10 g kidney, and thereafter the excess filtered is excreted in the urine.
Effect of methotrexate on the reabsorption of folic acid. Two experiments were performed 30 minutes after the administration of 30 mg of methotrexate to the anesthetized dogs. The dose levels used were 0.10 and 0.12 ug tritiated folic acid per 10 g kidney (no. 15 and 16, Table I ). From the experiments described above, complete reabsorption of the folic acid would be expected at these dose levels ( Figure 2) . It was found, however, that the two urinary recovery ratios were 0.81 and 0.73, respectively, indicating complete inhibition of folic acid reabsorption. The first value is somewhat higher than the control asymptotic value and suggests that there may be some competition for plasma protein-binding sites at these very high levels of methotrexate. The acid, the first passage excretion was followed by a steady state leak of small proportion. The inulin curve after the second injection represents the passage of material through the glomerular filter, and this is an index of the distribution of times taken by the unlabeled folic acid to appear in the urine. The concentration of tritiated folic acid that did appear rose more slowly than did the inulin concentration, and there was significant time lag between the inulin and the flushed tritiated folic acid peaks. There was prolonged flush of the tritiated folic acid from the tubular cells, in part owing to recirculation of the large dose of carrier folic acid. The essential data from three flush experiments are presented in Table II of the first dose was flushed from both kidneys and other body stores into the urine. The difference between the urinary excretion from the two kidneys was most evident during the first half of the collection. The excess radioactivity coming from the left side thus must have originated from material stored during the first passage.
A 15-minute collection of urine was pooled after a flushing dose in an experiment of the first type. Chromatography was carried out on this sample. Figure 5 illustrates that 97% of the effluent radioactivity was found in the folic acid peak.
DISCUSSION
Saturation of the reabsorptive mechanism. The results demonstrate that after a single intra-arterial dose, filtered tritiated folic acid is reabsorbed by the kidney. There is a maximum for initial reabsorption from tubular lumen to cell, and so this mechanism exhibits saturation. At highdose levels the mean transit times of folic acid and inulin are virtually identical. This indicates that the folic acid which appears in the urine has taken a direct course along the tubular lumen with (12) . The phenomenon of cellular storage thus complicates any attempt to estimate maximal transport from the tubular cell to the peritubular blood when some method is employed that entails transient changes in plasma concentration and expansion of tissue stores.
The renal tubular reabsorption of exogenously administered folic acid does not then resemble the kind of reabsorption usually inferred, i.e., a direct and rapid transport from tubular lumen to peritubular capillary blood, but rather resembles those processes in other tissues where a substance is rapidly taken up by the cells, stored and concentrated, metabolized slowly, and slowly transferred to the blood.
SUM MARY
The renal excretion of tritiated folic acid has been explored by using the single renal intra-arterial injection in the dog. Renal tubular reabsorption of folic acid was demonstrated. The initial reabsorptive mechanism from tubular lumen to cell exhibited saturation. It was inhibited by methotrexate. The reabsorbed folic acid was displaced into the urine from renal tubular cells by a large dose of unlabeled folic acid, (lemonstrating storage of folic acid in these cells under these experimental circumstances rather than rapid transport into the blood stream. The characteristics of this reabsorptive mechanism (saturation, inhibition, and countertransport) are compatible with a mobile, membrane, carrier-transport system for folic acid abutting upon the tubular lumen (5) .
